FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34242011000001108: MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103835301000001115 MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103835401000001111 MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Is a Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) capsules 50 capsule true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Has AMP MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) 50 capsule Has basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start